Editorial Comment.

Abstract

No AccessJournal of UrologyAdult Urology1 Jul 2020Editorial CommentThis article comments on the following:Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study Rosa Nadal, and Joaquim Bellmunt Rosa NadalRosa Nadal Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , and Joaquim BellmuntJoaquim Bellmunt Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000761.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, 204(1), pp. 69–70 Reference 1. : Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital. Urol Oncol 2013; 31: 1650. Google Scholar © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyJan 23, 2020, 12:00:00 AMHistological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study Volume 204Issue 1July 2020Page: 69-70 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Rosa Nadal Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Joaquim Bellmunt Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts More articles by this author Expand All Advertisement PDF DownloadLoading ...